BioSpace News Archive

Business

Novel Biotech is Warp Speed’s Slaoui’s Next Act

Centessa Pharmaceuticals, based in Cambridge, Massachusetts and London, launched what it is calling a “novel asset-centric pharmaceutical company.”

February 16, 2021

·

3 min read

·

Mark Terry

Business

Cellectis Stock Jumps Following Natural Killer Cell Deal with Cytovia

Shares of Cellectis Therapeutics were up nearly 10% in premarket trading after the company forged a deal with Cytovia Therapeutics to develop immunotherapies based on gene-edited allogeneic CAR T-cells.

February 16, 2021

·

2 min read

·

Alex Keown

Drug Development

Should Employers Require COVID-19 Vaccination Before Returning to the Office?

As COVID-19 vaccine rollouts intensify across the country, employers across all industries are trying to decide whether they should implement a mandatory vaccine policy before they let employees back into the office.

February 16, 2021

·

2 min read

·

Brandon May

The Path to Novel Antibiotics

Those magic bullets that save thousands of lives each year – antibiotics – aren’t as resilient or effective as they once were, thanks to resistant bacteria.

February 16, 2021

·

11 min read

·

Joseph Constance

Drug Development

FDA Places Partial Clinical Hold on Trial of Alzheimer’s Drug Atuzaginstat

According to a statement made by Cortexyme, the partial hold was placed on the development program for atuzaginstat after an FDA review of the trial data identified hepatic adverse events.

February 16, 2021

·

2 min read

·

Brandon May

Business

AstraZeneca CEO Pascal Soriot Took Home $21.4 Million in 2020

AstraZeneca Chief Executive Officer Pascal Soriot is seeing a significant return on the fruits of his company’s labor in 2020. Soriot’s annual compensation jumped a bit from the previous year to $21.4 million.

February 16, 2021

·

3 min read

·

Alex Keown

Drug Development

2021 Biopharma Update on the Novel Coronavirus: February 16

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for February 16, 2021.

February 16, 2021

·

6 min read

·

BioSpace Editorial Staff

Policy

North Korea Implicated in Another COVID-19 Hacking Attempt

Pfizer’s COVID-19 vaccine data has once again been threatened by hackers. The alleged theft of intellectual property has been laid at the feet of North Korea’s government.

February 16, 2021

·

2 min read

·

Alex Keown

Policy

BMS, Sanofi on Hook for $834 Million Over Deceptive Plavix Labeling in Hawaii

The companies have announced their intent to appeal the decision.

February 16, 2021

·

2 min read

·

Mark Zipkin

Drug Development

Bluebird bio Halts Sickle Cell Trials After Leukemia Diagnosis

Bluebird bio announced that it has placed its Phase I/II and Phase III trial of LentiGlobin gene therapy for sickle cell disease (SCD) on temporary suspension.

February 16, 2021

·

3 min read

·

Mark Terry